Product
KW-2450
2 clinical trials
2 indications
Indication
Breast CancerIndication
Solid TumorClinical trial
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of KW-2450 in Combination With Lapatinib and Letrozole in Subjects With Advanced or Metastatic Breast Cancer Whose Tumors Overexpress HER2Status: Terminated, Estimated PCD: 2012-12-01
Clinical trial
Open-Label, Sequential, Ascending, Multi-Dose, Phase 1 Study of KW-2450 as Monotherapy in Subjects With Previously Treated Advanced Solid TumorStatus: Completed, Estimated PCD: 2010-08-01